Analysis of:
Study Shows Children With ADHD Who Start on Strattera(R) are More Likely to Change Therapies (www.drugnewswire.com)
Strattera has been found by many clinicians to have questionable efficacy in treating ADD/ADHD. However, there are redeeming virtues to this medication which need to be further examined.
Analysis of:
J&J is Wired About the Web (www.pharmexec.com)
It's about time a major pharmaceutical company puts its money where the money is...internet promotion. This is the future, as younger generations rely increasingly on the web for just about everything.
Analysis of:
U.S. Proposes New Standards for Cord Blood Stem Cells (www.medscape.com)
Science and Politics dance around each other, but the future of stem cell research is gaining momentum and is predictably unstoppable.
Analysis of:
Pfizer ponders possible OTC version of Viagra (www.pharmatimes.com)
The FDA is giving consideration to OTC Viagra. At first this might seem to make sense, since the drug is wildly popular, and why should a "quality of life" drug require a doctor visit. However, Viagra's very popularity would make OTC availability potentially dangerous.
Analysis of:
Boehringer Ingelheim International R&D Press Conference, Vienna, Nov 8th, 2006, Clinical research and beyond (www.boehringer-ingelheim.com)
There is on the horizon a new drug working its way through clinical trials to boost a woman's sexual desire. Is this a good thing for women or only their male partners?
Analysis of:
Engineers building drug filled tooth (news.yahoo.com)
This concept, drug-filled tooth, would expand the modalities of drug delivery in a so-far uncharted direction.It would offer one solution to patient compliance problems.But it might meet with patient resistance.
Analysis of:
FDA Approves Duloxetine for Anxiety (journals.elsevierhealth.com)
Robust and carefully devised marketing efforts determine the success of new indications for existing medications. If this is handled correctly, sales can be substantially increased for Duloxetine, perhaps by as much as 50% or more.
Analysis of:
FDA:Sleeping pills can cause 'sleep-driving' (www.cnn.com)
There have been recent reports of parasomnias with oral sleep meds. Perhaps this is totally or partially an artifact of the increased use of sleep meds and the consequent increased time certain patients stay asleep.
Analysis of:
Self-Pay Markets In Health Care: Consumer Nirvana Or Caveat Emptor? (content.healthaffairs.org)
The self-pay market in health care is expanding as employers cut back benefits and HSA's proliferate. The Internet has an increasing role in patients' choices of providers.
Analysis of:
What's new in the antidepressant market when generics rule the roost? (atlanta-institute.com)
1. Currently, generic antidepressants are better and cheapter option than proprietary medications2. The way to go is targeting novel systems, e.g, glutamate, rather than same systems